knowledge -WSS

knowledge

author：leisure time 2025-09-28 21:05:49 - browse：47

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Results on Novartis prostate cancer therapy could expand its use

hotspot

WSS

Health tech investors get more selective as pandemic boom fades

Readout LOUD podcast: Live from the 2023 STAT Summit

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Readout: Friday, Oct. 20 biotech updates

The biotech scorecard for Q1: 17 stock

Feng Zhang CRISPR delivery startup lays off quarter of staff

leisure time

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Dobbs anniversary: the lost opportunity of abortion as health care

Smaller biotechs seek to piggyback on weight loss drug boom

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

The cancer drug shortage isn’t new — and neither are the solutions

Study on Amgen’s bispecific immunotherapy produces positive data

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Summit: How researchers deal with rejection

focus

STAT Summit: The economic case for universal basic health care

Health tech investors get more selective as pandemic boom fades

Health tech investors get more selective as pandemic boom fades

ADCs take center stage as promising cancer treatments

J&J lung cancer data amount to new salvo against AstraZeneca

Videos point to link between seizures and unexplained toddler deaths

hotspot

hotspot

hotspot

leisure time